Myriad Genetics, Inc. received an amended Schedule 13G filing showing that funds associated with Millennium now report a sizable passive stake in its common stock. Integrated Core Strategies (US) LLC reports beneficial ownership of 5,183,588 shares, representing 5.6% of the outstanding common stock.
Affiliates Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander each report beneficial ownership of 6,700,158 shares, or 7.2% of the class, with shared voting and dispositive power. The filing is certified as a passive investment, stating the securities were not acquired to change or influence control of Myriad Genetics.
Positive
None.
Negative
None.
Insights
Millennium reports a passive 7.2% Myriad Genetics stake via Schedule 13G/A.
The filing shows Millennium-related entities reporting beneficial ownership of 6,700,158 Myriad Genetics common shares, equal to 7.2% of the class, with shared voting and dispositive power. Integrated Core Strategies (US) LLC separately reports 5,183,588 shares, or 5.6%, also with shared powers.
The investors certify their holdings are not for the purpose of changing or influencing control, fitting the passive Schedule 13G framework. Actual market impact depends on how these positions are managed over time, but the disclosure mainly updates ownership transparency rather than signaling a defined corporate action.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 3)
Myriad Genetics, Inc.
(Name of Issuer)
Common Stock, par value $0.01 per share
(Title of Class of Securities)
62855J104
(CUSIP Number)
12/31/2025
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
SCHEDULE 13G
CUSIP No.
62855J104
1
Names of Reporting Persons
Integrated Core Strategies (US) LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
5,183,588.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
5,183,588.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
5,183,588.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.6 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP No.
62855J104
1
Names of Reporting Persons
Millennium Management LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
6,700,158.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
6,700,158.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
6,700,158.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.2 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP No.
62855J104
1
Names of Reporting Persons
Millennium Group Management LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
6,700,158.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
6,700,158.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
6,700,158.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.2 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP No.
62855J104
1
Names of Reporting Persons
Israel A. Englander
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
6,700,158.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
6,700,158.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
6,700,158.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.2 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Myriad Genetics, Inc.
(b)
Address of issuer's principal executive offices:
322 North 2200 West, Salt Lake City, Utah 84116
Item 2.
(a)
Name of person filing:
Integrated Core Strategies (US) LLC
Millennium Management LLC
Millennium Group Management LLC
Israel A. Englander
(b)
Address or principal business office or, if none, residence:
Integrated Core Strategies (US) LLC
c/o Millennium Management LLC
399 Park Avenue
New York, New York 10022
Millennium Management LLC
399 Park Avenue
New York, New York 10022
Millennium Group Management LLC
399 Park Avenue
New York, New York 10022
Israel A. Englander
c/o Millennium Management LLC
399 Park Avenue
New York, New York 10022
(c)
Citizenship:
Integrated Core Strategies (US) LLC - Delaware
Millennium Management LLC - Delaware
Millennium Group Management LLC - Delaware
Israel A. Englander - United States
(d)
Title of class of securities:
Common Stock, par value $0.01 per share
(e)
CUSIP No.:
62855J104
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
See response to Item 9 on each cover page.
(b)
Percent of class:
See response to Item 11 on each cover page.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
See response to Item 5 on each cover page.
(ii) Shared power to vote or to direct the vote:
See response to Item 6 on each cover page.
(iii) Sole power to dispose or to direct the disposition of:
See response to Item 7 on each cover page.
(iv) Shared power to dispose or to direct the disposition of:
See response to Item 8 on each cover page.
The securities disclosed herein as potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management LLC). The foregoing should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the securities held by such entities.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
If a group has filed this schedule pursuant to §240.13d-1(b)(1)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to §240.13d-1(c) or §240.13d-1(d), attach an exhibit stating the identity of each member of the group.
See Exhibit I
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Integrated Core Strategies (US) LLC
Signature:
/s/ Gil Raviv
Name/Title:
Gil Raviv, Global General Counsel
Date:
02/10/2026
Millennium Management LLC
Signature:
/s/ Gil Raviv
Name/Title:
Gil Raviv, Global General Counsel
Date:
02/10/2026
Millennium Group Management LLC
Signature:
/s/ Gil Raviv
Name/Title:
Gil Raviv, Global General Counsel
Date:
02/10/2026
Israel A. Englander
Signature:
/s/ Israel A. Englander
Name/Title:
Israel A. Englander
Date:
02/10/2026
Comments accompanying signature: ** INTEGRATED CORE STRATEGIES (US) LLC
By: Integrated Holding Group LP, its Managing Member
By: Millennium Management LLC, its General Partner
Exhibit Information
Exhibit I: Joint Filing Agreement, dated as of February 10, 2026, by and among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.
What stake in Myriad Genetics (MYGN) does Millennium report in this Schedule 13G/A?
Millennium-related entities report beneficial ownership of 6,700,158 Myriad Genetics common shares, representing 7.2% of the outstanding class. They hold shared voting and dispositive power over these shares, as disclosed in the amended Schedule 13G filing.
How many Myriad Genetics (MYGN) shares does Integrated Core Strategies (US) LLC own?
Integrated Core Strategies (US) LLC reports beneficial ownership of 5,183,588 Myriad Genetics common shares. This position represents 5.6% of the company’s common stock, with shared voting and shared dispositive power disclosed for this stake in the filing.
Is Millennium’s Myriad Genetics (MYGN) position classified as passive or activist?
The position is certified as passive. The investors state the Myriad Genetics securities were not acquired and are not held to change or influence control, consistent with a Schedule 13G filing rather than an activist Schedule 13D approach.
Who are the reporting persons in the Myriad Genetics (MYGN) Schedule 13G/A?
The reporting persons are Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander. Each reports beneficial ownership and shared voting and dispositive power over specified blocks of Myriad Genetics common stock.
What event date triggers this Myriad Genetics (MYGN) Schedule 13G/A amendment?
The stated event date for this Schedule 13G/A amendment is December 31, 2025. That date is used to determine the beneficial ownership percentages and share amounts reported for Myriad Genetics common stock in the filing.
What does Israel A. Englander report regarding Myriad Genetics (MYGN) ownership?
Israel A. Englander reports beneficial ownership of 6,700,158 Myriad Genetics shares, equal to 7.2% of the class. He reports zero sole voting or dispositive power but shared voting and shared dispositive power over the reported shares, alongside affiliated entities.
